Concepedia

Shigeo Hayashi

SH

Statistics

Publications

10

Citations

347

H-Index

10

Active since

1969

Affiliations

Pfizer (Japan)(Current)

Pfizer (United States)

National Institute of Genetics

Shigeo Hayashi is an author at Pfizer (Japan) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1969–2012

10

Publications

10

Specification of the embryonic limb primordium by graded activity of Decapentaplegic

Satoshi Goto, Shigeo Hayashi · Development · 1997 · 104 citations

, , +17

Novel Non-Peptide Nociceptin/Orphanin FQ Receptor Agonist, 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3<i>R</i>)-3-piperidinyl]-1<i>H</i>-benzimidazole: Design, Synthesis, and Structure−Activity Relationship of Oral Receptor Occupancy in the Brain for Orally Potent Antianxiety Drug

Shigeo Hayashi, Akiko Hirao, Aki Imai et al. · Journal of Medicinal Chemistry · 2009 · 46 citations · Full text

, , +16

Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure–activity relationship for anti-inflammatory drug

Shigeo Hayashi, Naomi Ueno, Akio Murase et al. · European Journal of Medicinal Chemistry · 2012 · 41 citations · Full text

, , +16

Pharmacological Characterization of the Newly Synthesized Nociceptin/Orphanin FQ–Receptor Agonist 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole as an Anxiolytic Agent

Akiko Hirao, Aki Imai, Yutaka Sugie et al. · Journal of Pharmacological Sciences · 2008 · 36 citations · Full text

, , +14

Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: Design, synthesis, and structure–activity relationship

Shigeo Hayashi, Yoko Sumi, Naomi Ueno et al. · Biochemical Pharmacology · 2011 · 25 citations

, , +16

1–5 of 10